Explore the new AI foundation model by Insilico Medicine and Liquid AI for efficient pharmaceutical research on private ...
Drug discovery has traditionally been a reductive process—narrowing down, filtering out, and optimizing within established constraints. Generative AI turns that on its head. It is an expansive force, ...
The GPCRact AI model goes beyond AlphaFold3 by predicting whether drugs functionally activate G-protein-coupled receptors ...
NVIDIA Nemotron 3 omni-understanding models power AI agents delivering natural conversations, complex reasoning and advanced visual ...
About Insilico Medicine: Insilico Medicine is a clinical-stage biotechnology company using AI for drug development across cancer, fibrosis, immunity, central nervous system diseases, and aging-related ...
Explore the latest developments showcased at World ADC, highlighting smarter payloads and precise targeting in drug discovery.
Genetically-humanized FcRn mice provide translational pharmacokinetics (PK) and pharmacodynamics (PD) data for antibody-based therapeutics. The image illustrates a therapeutic antibody (blue) adhering ...
A recent study published in the journal Molecular Psychiatry provides evidence that a combination of non-invasive brain scanning and computer modeling can successfully measure how a dementia drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results